(Q31068505)

English

Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial (English)

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

patient satisfaction

1 reference

based on heuristic

inferred from title

author name string

Georges M Gharabawi

1

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Andrew Greenspan

2

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Marcia F T Rupnow

3

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Colette Kosik-Gonzalez

4

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Cynthia A Bossie

5

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Young Zhu

6

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Amir H Kalali

7

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

A George Awad

8

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

publication date

20 October 2006

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

6

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

45

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

https://scigraph.springernature.com/pub.10.1186/1471-244x-6-45

0 references

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1626455

21 June 2018

Risperidone versus olanzapine for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1626455

21 June 2018

New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1626455

21 June 2018

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1626455

21 June 2018

A rating scale for depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1626455

21 June 2018

How valid and reliable are patient satisfaction data? An analysis of 195 studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1626455

21 June 2018

Patient satisfaction and administrative measures as indicators of the quality of mental health care.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1626455

21 June 2018

The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1626455

21 June 2018

A rating scale for extrapyramidal side effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1626455

21 June 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1626455

21 June 2018

Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1626455

21 June 2018

Satisfaction with in-patient psychiatric services. Relationship to patient and treatment factors.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-45

21 January 2018

Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice: a naturalistic comparative study

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-45

21 January 2018

Short report: comparison of patient satisfaction and burden of adverse effects with novel and conventional neuroleptics: a naturalistic study

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-45

21 January 2018

A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-45

21 January 2018

The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-45

21 January 2018

Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1626455

25 November 2018

A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17054789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures

1 reference

https://pubmed.ncbi.nlm.nih.gov/17054789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Satisfaction with care reported by psychiatric inpatients Relationship to diagnosis and medical treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17054789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient satisfaction with, and acceptability of, atypical antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17054789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-244X-6-45

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-244x-6-45

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31068505&oldid=1589790849"